JP2022532370A5 - - Google Patents

Info

Publication number
JP2022532370A5
JP2022532370A5 JP2021568072A JP2021568072A JP2022532370A5 JP 2022532370 A5 JP2022532370 A5 JP 2022532370A5 JP 2021568072 A JP2021568072 A JP 2021568072A JP 2021568072 A JP2021568072 A JP 2021568072A JP 2022532370 A5 JP2022532370 A5 JP 2022532370A5
Authority
JP
Japan
Prior art keywords
immunoglobulin
domain
nucleic acid
protein
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532370A (ja
Filing date
Publication date
Priority claimed from GBGB1906870.9A external-priority patent/GB201906870D0/en
Priority claimed from GBGB1906872.5A external-priority patent/GB201906872D0/en
Application filed filed Critical
Priority claimed from PCT/GB2020/051199 external-priority patent/WO2020229842A1/en
Publication of JP2022532370A publication Critical patent/JP2022532370A/ja
Publication of JP2022532370A5 publication Critical patent/JP2022532370A5/ja
Pending legal-status Critical Current

Links

JP2021568072A 2019-05-15 2020-05-15 結合分子 Pending JP2022532370A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1906870.9A GB201906870D0 (en) 2019-05-15 2019-05-15 Binding molecules
GB1906872.5 2019-05-15
GBGB1906872.5A GB201906872D0 (en) 2019-05-15 2019-05-15 Binding molecules
GB1906870.9 2019-05-15
PCT/GB2020/051199 WO2020229842A1 (en) 2019-05-15 2020-05-15 Binding molecules

Publications (2)

Publication Number Publication Date
JP2022532370A JP2022532370A (ja) 2022-07-14
JP2022532370A5 true JP2022532370A5 (https=) 2023-05-23

Family

ID=70847430

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568072A Pending JP2022532370A (ja) 2019-05-15 2020-05-15 結合分子

Country Status (10)

Country Link
US (2) US20220227850A1 (https=)
EP (2) EP3969474A1 (https=)
JP (1) JP2022532370A (https=)
KR (1) KR20220008839A (https=)
CN (1) CN113840835B (https=)
AU (1) AU2020275926A1 (https=)
CA (1) CA3136598A1 (https=)
IL (1) IL287555A (https=)
SG (1) SG11202111671QA (https=)
WO (2) WO2020229844A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3565841A1 (en) 2017-01-06 2019-11-13 Crescendo Biologics Limited Single domain antibodies to programmed cell death (pd-1)
EP3710478A1 (en) 2017-11-13 2020-09-23 Crescendo Biologics Limited Molecules that bind to cd137 and psma
GB201802573D0 (en) 2018-02-16 2018-04-04 Crescendo Biologics Ltd Therapeutic molecules that bind to LAG3
KR102618718B1 (ko) * 2021-01-11 2023-12-29 주식회사 유틸렉스 항-4-1bb 항체 및 pd-1 단백질 또는 이의 단편을 포함하는 이중특이적 에피토프 결합 단백질 및 이의 용도
GB202205589D0 (en) 2022-04-14 2022-06-01 Crescendo Biologics Ltd Mesothelin binders
TW202448926A (zh) 2023-02-17 2024-12-16 比利時商艾伯霖克斯公司 結合新生兒fc受體之多肽

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115256D0 (en) 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
US9321832B2 (en) * 2002-06-28 2016-04-26 Domantis Limited Ligand
GB2398784B (en) 2003-02-26 2005-07-27 Babraham Inst Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
US20080267949A1 (en) * 2006-12-05 2008-10-30 Ablynx N.V. Peptides capable of binding to serum proteins
WO2012072731A2 (en) * 2010-12-01 2012-06-07 Glaxo Group Limited Improved anti-serum albumin binding single variable domains
EP2723771B1 (en) * 2011-06-23 2019-09-11 Ablynx NV Serum albumin binding proteins
EP4151658A1 (en) * 2012-05-07 2023-03-22 Elasmogen Limited Single domain binding molecule
WO2014111550A1 (en) * 2013-01-17 2014-07-24 Glaxosmithkline Intellectual Property Development Limited Modified anti-serum albumin binding proteins
DK3209698T4 (da) 2014-10-22 2022-04-04 Crescendo Biologics Ltd Transgene mus
EP3493844A4 (en) * 2016-05-20 2021-03-24 Harpoon Therapeutics Inc. SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
RU2022101604A (ru) * 2016-12-07 2022-03-29 Аблинкс Нв Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином
CN107674122A (zh) * 2016-12-28 2018-02-09 天津天锐生物科技有限公司 一种识别人血清白蛋白的单域抗体
EP3565841A1 (en) * 2017-01-06 2019-11-13 Crescendo Biologics Limited Single domain antibodies to programmed cell death (pd-1)
GB201711068D0 (en) * 2017-07-10 2017-08-23 Crescendo Biologics Ltd Therapeutic molecules binding PSMA
CA3070253A1 (en) * 2017-07-19 2019-01-24 Vib Vzw Serum albumin binding agents
EP3470426A1 (en) * 2017-10-10 2019-04-17 Numab Therapeutics AG Multispecific antibody
EP3710478A1 (en) * 2017-11-13 2020-09-23 Crescendo Biologics Limited Molecules that bind to cd137 and psma

Similar Documents

Publication Publication Date Title
JP2022532370A5 (https=)
US11649295B2 (en) Asymmetric multispecific antibodies
CA2736277C (en) Display library for antibody selection
JP2021130681A (ja) 改善された免疫グロブリン可変ドメイン
JP2021520832A5 (https=)
JP2020506898A5 (https=)
JP2015524404A (ja) 高度に保存された標的に対するラクダ科動物由来の配列を含む抗体
CN101432015A (zh) 功能性抗体
JP2021526820A (ja) 癌治療のための抗ｏｘＭＩＦ／抗ＣＤ３抗体
JP2020524510A5 (https=)
KR20180077144A (ko) 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리
JP2021512159A5 (https=)
EP2089432A1 (en) Anti-glycoprotein vi scfv fragment for treatment of thrombosis
JP2010524435A5 (https=)
JP2021530244A5 (https=)
JP2023511963A5 (https=)
JP2017509323A5 (https=)
JP2022540610A5 (https=)
JP2021503292A5 (https=)
JP2024527020A5 (https=)
JP2023533533A5 (https=)
JPWO2022224997A5 (https=)
AU2021411896B2 (en) Bi- or multi-specific antibody
JP2010004895A (ja) ヒト化ニワトリ抗体の製造方法
JP2024535851A5 (https=)